The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 24 February 2004, www.theannals.com, DOI 10.1345/aph.1D328.
 The Annals of Pharmacotherapy: Vol. 38, No. 4, pp. 710-713. DOI 10.1345/aph.1D328
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corman, S. L
Right arrow Articles by Ansani, N. T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corman, S. L
Right arrow Articles by Ansani, N. T

DRUG INFORMATION ROUNDS

OBJETIVO: Evaluar el uso de una dosis baja de granisetrón en el tratamiento profiláctico de las nauseas y vómitos postoperatorios (NVPO).

FUENTES DE INFORMACIÓN: Se identificó estudios clínicos por medio de búsquedas en PubMed y OVID (1966–julio 2003); también se repasó información proveída por el manufacturero.

SÍNTESIS DE DATOS: La preocupación con la seguridad asociada a droperidol y a la disponibilidad limitada de otros agentes ha creado una necesidad en la reestructuración de las guiás profilácticas para las NVPO. Se ha propuesto recientemente que el granisetrón puede ser eficaz en una dosis que sea un décimo de la dosis que fue aprobada por el FDA. Se evalúa la evidencia conflictiva para este régimen en este reporte.

CONCLUSIONES: De acuerdo con la escasez de datos de apoyo, este régimen no se recomienda para la profilaxis de las NVPO en pacientes en riesgo para las NVPO.

www.theannals.com, DOI 10.1345/aph.1D328


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M. Balki, S. Kasodekar, S. Dhumne, and J. C. A. Carvalho
Prophylactic Granisetron Does Not Prevent Postdelivery Nausea and Vomiting During Elective Cesarean Delivery Under Spinal Anesthesia
Anesth. Analg., March 1, 2007; 104(3): 679 - 683.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corman, S. L
Right arrow Articles by Ansani, N. T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corman, S. L
Right arrow Articles by Ansani, N. T

homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.